Snowball logo
logo
NOVN_logo

Novartis AG

Fr128.00-Fr0.88Β  (0.68%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
43,97443,46146,66051,72257,126.454,785.1
COGS
11,73511,58212,47212,82714,26814,086.4
Gross Profit
32,23931,87934,18838,89542,858.440,698.7
Operating Expenses & Income
Operating Income
10,0567,9469,76914,54417,795.216,359.2
Total Operating Expenses
22,18323,93324,41924,35125,063.224,339.5
R&D Expenses
8,6419,17211,37110,02211,195.411,246.8
Selling General & Admin Expenses
14,81514,19012,51712,56613,23813,125
Earnings from Continuing Operations
Interest Expense
(904.8)(860.2)(916.9)(1,005.6)(1,237.2)(1,376.9)
Interest Income
14,6285436275681,156591
Income Tax Expense
1,6251,1285511,7012,498.52,749
Net Income
Net Income
24,0216,95514,85011,94114,649.312,650.6
Supplemental
EBIT
25,3177,9779,97814,64618,379.716,769.6
EBITDA
30,91414,68218,25520,71523,95822,039.2
In millions of CHF, except % and values per 1 share